Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hookworm vaccines.

David J Diemert1, Jeffrey M Bethony, Peter J Hotez

  • 1Sabin Vaccine Institute, George Washington University, Washington, DC 20037, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|January 4, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influenza A and B Viral Shedding in Adults Immunized with Live Attenuated Influenza Vaccine.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Na-GST-1 adsorbed on Alhydrogel co-administered with different Toll-like receptor agonists in hookworm-naive adults using a controlled human infection model in the USA: a phase 2, double-blind, randomised controlled trial.

The Lancet. Infectious diseases·2026
Same author

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances.

Vaccine·2026
Same author

Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination.

Vaccine·2025
Same author

Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial.

Vaccine·2025
Same author

Advancing HIV and Cancer Research: Implementing an AIDS and Cancer Specimen Resource in Latin America.

Biopreservation and biobanking·2025
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Larger Blood Volume Increases Detection of Fastidious Mycobacteria and Fungi in Blood Culture.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Wanted: A Relevant Correlate of Protection for Dengue Vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Developing a hookworm vaccine is crucial for global health, as current treatments are unsustainable. Research is advancing on a novel vaccine targeting both larval and adult stages of the parasite.

Area of Science:

  • Parasitology
  • Vaccinology
  • Global Health

Background:

  • Hookworm infection, caused by Necator americanus and Ancylostoma duodenale, is a widespread soil-transmitted helminthiasis.
  • It leads to significant morbidity, including chronic anemia and protein malnutrition, impacting millions globally.
  • Current control strategies relying on mass drug administration are unsustainable, necessitating novel interventions.

Purpose of the Study:

  • To review the progress in developing vaccines against hookworm infection.
  • To highlight the preclinical and clinical testing of the Necator americanus Ancylostoma Secreted Protein-2 (NASP-2) hookworm vaccine.
  • To outline future directions for a multi-stage hookworm vaccine.

Main Methods:

  • Review of existing literature on hookworm vaccine development.

Related Experiment Videos

  • Analysis of preclinical data for NASP-2 vaccine candidates.
  • Examination of early-phase clinical trial findings for hookworm vaccines.

    • Main Results:

    • Preclinical and initial clinical testing of the NASP-2 hookworm vaccine shows promise.
    • Development is progressing towards a combination vaccine targeting multiple parasite life stages.
    • A multi-component vaccine strategy is planned, including larval and adult worm antigens.

    Conclusions:

    • Vaccine development offers a sustainable strategy to control hookworm infections.
    • Targeting multiple life stages of the hookworm is a key approach for efficacy.
    • Further research and clinical trials are essential to bring a hookworm vaccine to fruition.